Related Experiment Video
Updated: Mar 16, 2026

Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
Why do parents decline newborn intramuscular vitamin K prophylaxis?
Hayleigh Miller1, Nicola Kerruish2, Roland S Broadbent3
1Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Objective:
To explore the influencing factors and reasoning of parents who opt out of intramuscular vitamin K prophylaxis for their newborn.
Design:
We conducted a qualitative study with 15 families from the Otago/Southland region of New Zealand. Semistructured interviews explored their choice to opt out of intramuscular vitamin K prophylaxis and thematic analysis was used to elucidate themes that captured important aspects of this parental decision-making process.
Results:
Parents opt out of intramuscular vitamin K for a variety of reasons. These were clustered into three main themes: parents' beliefs and values (philosophy and spirituality), concerns about their child's welfare (pain and potential side effects) and external influencing factors (family, friends, media and health professionals). As part of a wider family hesitancy towards medical intervention, the majority of parents also raised concerns regarding other perinatal or childhood interventions.
Conclusion:
Many factors influence parental decision making and lead to a decision to opt out of newborn intramuscular vitamin K prophylaxis. Due to strong parallels with other common childhood interventions, these findings have relevance for vitamin K prophylaxis and for other healthcare interventions in childhood.
More Related Videos
10:15Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
Published on: September 15, 2014
04:33Author Spotlight: Intrathecal Injection – An Efficient and Reliable Delivery Method to Test the Efficacy of Gene Editing in Neonatal Mouse Brains
Published on: March 8, 2024
Related Concept Videos
Drug Dosing: Infants and Children
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Parenteral Anesthetics: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion
Anticoagulant Drugs: Low-Molecular-Weight Heparins